Mega Genomics (6667.HK) Stock Price
Mega Genomics Price
Revenue has compounded at 15.1% per year over the past 6 years to 288.30 M CNY. Earnings per share have grown at 1.6% per year over the last 6 years. Mega Genomics's net margin stands at 10.7%, down from 33.3% several years earlier. Analysts set a median price target of 17.03 CNY, implying 182.1% above the current price. Of 7 analysts, 6 rate the stock a buy — an overall Buy consensus.
Mega Genomics stock price
Mega Genomics business model & stock analysis
Frequently asked questions about Mega Genomics
Analysts currently set an average price target of 17.03 CNY for the Mega Genomics stock (median: 17.03 CNY), implying +182.3 % versus the latest price. The consensus is based on 7 analyst ratings.
7 analysts currently rate the Mega Genomics stock: 6 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the Mega Genomics share trades at 0.80 EUR (6.04 CNY).
The revenue cannot currently be calculated for Mega Genomics.
The profit cannot currently be calculated for Mega Genomics.
The P/E ratio cannot be calculated for Mega Genomics at the moment.
The P/S cannot be calculated for Mega Genomics currently.
The Eulerpool Quality Score for Mega Genomics is 3/10.
The ISIN of Mega Genomics is KYG5960G1047. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of Mega Genomics is 6667.HK. The ticker symbol is used to trade Mega Genomics shares on the stock exchange.
Mega Genomics stock
Mega Genomics Peer Group
Mega Genomics FIGI
All fundamentals and in-depth analysis of Mega Genomics
Our stock analysis for Mega Genomics stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mega Genomics. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.